Group One Trading, L.P. Roivant Sciences Ltd. Transaction History

Group One Trading, L.P.

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	SELL	$10.36 - $11.74 $52,463 - $59,451	-5,064 Reduced 10.2%	44,604 $471,000
Q1 2024 May 10, 2024	BUY	$9.87 - $11.8 $490,223 - $586,082	49,668 New	49,668 $523,000
Q3 2023 Nov 09, 2023	BUY	$9.76 - $13.19 $521,310 - $704,517	53,413 Added 292.29%	71,687 $837,000
Q2 2023 Aug 09, 2023	BUY	$7.09 - $10.08 $129,562 - $184,201	18,274 New	18,274 $184,000
Q3 2022 Nov 09, 2022	BUY	$0.51 - $4.84 $5,661 - $53,724	11,100 New	11,100 $36,000

311

508M

1.26M

2.52M

Ticker ROIV
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 704,382,976
Market Cap $8.94B
Description
Roivant Sciences Ltd., a biopharmaceutical and healthcare technology company that researches and develops medicines. The company develops product candidates for the treatment of various therapeutics, including solid tumors, sickle cell diseases, hypophosphatasia, oncologic malignancies, psoriasis, atopic dermatitis, vitiligo, hyperhidrosis, acne...

Get notified when there are updates to the investment portfolio of Group One Trading, L.P., based on Form 13F filings with the SEC.

Stay updated on Group One Trading, L.P. with notifications on news.